US moves to sell gene-edited mushrooms fuel doubts over British ban on GM imports
By Robin McKie,
The Guardian
| 04. 23. 2016
Untitled Document
American regulators have allowed the cultivation and sale of two crops modified with the gene-editing technique known as Crispr. The crops – a white button mushroom and a form of corn – are the first Crispr plants to be permitted for commercial use in the US.
The move is a boost for new technology in the creation of foodstuffs, but is expected to worsen the considerable confusion in Britain over the use of gene-editing in agriculture and the importing of crops created using such technology.
A committee of European commission regulators was expected to report last month on whether gene-edited crops should be classed as genetically-modified organisms or should be freed from the severe restrictions concerning GMOs in Europe. At the last minute it announced a delay in its verdict – to the dismay of many UK scientists.
“The committee knew it would be highly controversial, no matter what decision it made, so they have kicked the issue into the long grass, and that is very damaging,” said crop scientist Professor Huw Jones of Aberystwyth university.
“Researchers...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...